Yuhan Corporation (KRX:000105)
South Korea · Delayed Price · Currency is KRW 93,700
-1,300 (-1.37%)
Last updated: Feb 5, 2026, 2:36 PM KST
Yuhan Market Cap
Yuhan has a market cap or net worth of 8.01 trillion as of February 5, 2026. Its market cap has decreased by -19.97% in one year.
Market Cap
8.01T
Enterprise Value
8.03T
Revenue
2.14T
Ranking
n/a
PE Ratio
119.54
Stock Price
93,700.00
Market Cap Chart
Since April 26, 2001, Yuhan's market cap has increased from 231.73B to 8.01T, an increase of 3,358.14%. That is a compound annual growth rate of 15.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 8.12T | -3.24% |
| Dec 30, 2025 | 8.39T | -6.18% |
| Dec 30, 2024 | 8.94T | 73.59% |
| Dec 28, 2023 | 5.15T | 25.86% |
| Dec 29, 2022 | 4.09T | -3.94% |
| Dec 30, 2021 | 4.26T | -9.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yuhan | 8.07T |
| Hanmi Pharm. | 6.85T |
| Celltrion Pharm | 3.11T |
| Hanall Biopharma | 2.73T |
| Daewoong Pharmaceutical | 1.94T |
| GC Biopharma | 1.87T |
| Ildong Pharmaceutical | 1.20T |
| Chong Kun Dang Pharmaceutical | 1.12T |